Open access peer-reviewed chapter

Septic Shock in Older People

Written By

Mike Yoshio Hamasaki, Marcel Cerqueira César Machado and Fabiano Pinheiro da Silva

Submitted: 08 November 2016 Reviewed: 23 February 2017 Published: 23 August 2017

DOI: 10.5772/68080

From the Edited Volume


Edited by Vijay Kumar

Chapter metrics overview

1,344 Chapter Downloads

View Full Metrics


Sepsis is a complex condition that is initiated by infection. The incidence of sepsis and its severity are higher at an older age (mean age of approximately 65 years). Clinical manifestations of sepsis are derived from systemic inflammatory response syndrome. Age‐related defects in immunity are shown by changes in cellular and humoral immunity. Recent studies have shown significant changes in the innate response (e.g., changes in toll‐like receptor expression, abnormal activation of mitogen-activated protein kinases, and production of reactive oxygen species) in older people. Transcriptomic analysis on a large scale has provided interesting information showing that specific groups of patients actually have singular profiles for inflammatory responses. Findings from our research group have identified major molecular pathways that are particularly affected in older people during sepsis. Oxidative phosphorylation pathways and mitochondrial dysfunction are altered the most in older people with sepsis compared with younger patients with sepsis. These pathways might have a pivotal role in worsening clinical outcomes compared with younger people with sepsis. The mechanisms leading to specific dysfunction of several signaling pathways in the immune response of older people are complex and appear to involve multiple factors, including environmental factors, microRNAs, and epigenetic changes.


  • sepsis
  • aging
  • inflammation
  • transcriptomics

1. Introduction

Sepsis is a complex disease that is triggered by infection and characterized by massive deregulation of the immune system [1]. Clinical manifestations of sepsis, such as fever, a hypercoagulable state, and peripheral hypotension, are derived from systemic inflammatory response syndrome (SIRS). Clinically, SIRS can be classified according to the nature of the symptoms manifested by the individual, such as (1) hypothermia or fever, (2) tachycardia, (3) tachypnea, and (4) leukocytosis or leucopenia [2]. Infection is probably the most common cause of SIRS, associated with the action of cytokines that are derived from cells of the immune system acting in organs and systems with specific receptors [3]. Figure 1 illustrates the stages of evolution of sepsis using SIRS as the standard diagnosis.

Figure 1.

Evolution of sepsis.

Recently, the Journal of the American Medical Association (JAMA) published the “Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis‐3).” This is the most recent international consensus on diagnostic criteria for sepsis and septic shock. According to the new criteria for the diagnosis of sepsis, organ dysfunction promoted by the disease must be considered [4]. In this regard, SIRS is no longer used as a diagnostic criterion for sepsis, and organ dysfunction is represented by an increase of two or more points in the Sequential Organ Failure Assessment (SOFA) score. The SOFA score is obtained by using a scoring scheme that assigns one to four points. The SOFA score uses variables, such as the platelet count, bilirubin, and oxygenation index, using variables as scoring of platelet, bilirubin, oxygenation index, use of vasoactive drugs, the Glasgow Coma Scale, and creatinine.

Septic patients have an average age of approximately 65 years [5], and the incidence of sepsis and its severity are significantly increased at an older age [6, 7]. Factors that contribute to this increase include defects in the integrity of epithelial barriers, dysfunction in the cough reflex, changes in level of consciousness, immobility, comorbidities, presence of invasive medical devices, a decrease in physiological reserves, endocrine disorders, and malnutrition [8, 9].

Immune defects associated with age are shown by changes in cellular and humoral immunity [10]. Aging is associated with an increase in memory T‐cell [9] repertoire and in the responses of types 1 and 2 [11, 12]. B cells gradually decrease with age, while the production of immunoglobulin increases [13].

Initial reports described preservation of the innate immune response in older people [14], but recent studies have shown significant changes in these components [9]. Studies have suggested changes in expression and toll‐like receptor (TLR) function as age advances and that this affects the response to pathogens [15]. An increase in the basal levels of inflammatory mediators [16, 17], aberrant activation of mitogen-activated protein kinases [18], an increased number of apoptotic cells [19], defects in the process of phagocytosis, production of reactive oxygen species (ROS), and deregulation in expression of accessory molecules have been reported [20]. Indeed, evidence indicates that older people produce higher levels of pro‐inflammatory cytokines, coagulation factors, and acute phase proteins in the absence of infection [2123].

However, the inflammatory response of older people in the presence of a serious infectious process remains controversial. Because of the increasing aging population, this issue has received great attention from the scientific community ( Figure 2 ). Studies have identified a higher mortality, inflammatory response, hypothermia, disseminated intravascular coagulation, and apoptosis in aged animals undergoing experimental models of sepsis [24]. Aspects of immunosenescence and a more intense inflammatory response in aged rodents with sepsis have been well characterized [25, 26]. However, intriguingly, clinical studies (including our own research group) have detected a similar immune response profile when comparing older patients with sepsis with younger patients [2730].

Figure 2.

Population aging around the world. Source: World Health Organization—World report on Ageing and Health —2015.


2. Transcriptomics in sepsis

Transcriptomics is a powerful technique, which can be used for detecting new therapeutic biomarkers and targets in the field of infectious diseases [31, 32]. Several studies of gene expression in sepsis on a large scale have been performed. These studies have shown persistent repression of genes of adaptive immunity and massive activation of pathways of innate immunity in septic shock [33]. Using RNA obtained from total blood, Wong and colleagues [34] identified activation of oxidative phosphorylation, signaling by interleukin (IL)‐10, TLRs, TREM, NF‐κB, the protein ubiquitination pathway, and IL‐6 in macrophages. These authors also described suppression of specific pathways of T lymphocytes and signaling by chemokines (CCR5). Similarly, Cvijanovich and colleagues [35] detected activation of TLRs, IL‐10, IL‐6, and NF‐κB with concomitant suppression of T lymphocytes. Additionally, they detected activation of protein in the acute phase, p38, the complement system, and some nuclear receptors (LXR and PPAR) in association with repression of antigenic presentation pathways.

Shanley et al. [36] used total blood RNA from septic patients and performed global gene expression experiments. Their results agree with those studies described above in many aspects, except that they also identified integrin activation, IGF‐1, GM‐CSF, and insulin receiver. Tang et al. [37] described activation of apoptosis genes, including CARD12, APAF1, and ELMOD2, in mononuclear cells of septic patients. Moreover, a recent study in patients with severe blunt trauma described surprisingly similar results with activation of a large number of genes involved in inflammation, pattern recognition, and antimicrobial function [38]. This study also showed simultaneous repression of genes involved in antigenic presentation and proliferation of T cells, suggesting that severe physiological stress, regardless of the cause, has similar genetic signatures.


3. Sepsis: a heterogeneous disease

Sepsis affects different groups of patients (e.g., those with an older age, diabetes, nephropathy, multiple trauma, surgery, and obesity). Historically, each specific group of patients is thought to be present with a characteristic inflammatory response. In the course of sepsis, transition of the inflammatory response to standard immunosuppression has been suggested to explain the disappointing results obtained by clinical studies that investigated the use of anti‐inflammatory drugs in this population of patients [3941]. Transcriptomic analysis on a large scale has provided interesting information in this regard, showing that specific groups of patients actually have singular profiles [4244]. However, a recently published systematic review was unable to detect distinct pro‐inflammatory and anti‐inflammatory phases in sepsis or differences in gene expression when analyzing different sub‐populations [45]. Therefore, this issue remains extremely controversial.

To the best of our knowledge, our research group was the first to study characteristics of sepsis in older people through transcriptomics analysis on a large scale [46]. We detected 388 genes that were differentially expressed between older and younger people with sepsis and 442 genes among older and healthy younger subjects.

Interestingly, oxidative phosphorylation pathways and mitochondrial dysfunction were the most altered in older people with sepsis compared with younger patients with sepsis. Other relevant pathways were signaling by TGF‐β, Wnt/β‐catenin, and calcium, as well as pathways that have been less studied in this disease, such as those involved in nerve growth factor and bone morphogenic protein.

Initially, our results confirmed that, regarding the production of TNF‐α, IL‐6, IL‐1β, TLRs, and other classical markers of cell activation, younger and older people respond similarly to a severe infectious insult. Some other pathways, as described above, appear to be more affected in older patients in a critical condition than in younger patients. We consider that defects of mitochondrial function and oxidative phosphorylation, and signaling by TGF‐β, Wnt/β‐catenin, bone morphogenic protein, nerve growth factor, and calcium are different in older patients with sepsis than in younger patients with sepsis.

Confirming our hypothesis, we observed a notable decrease in gene expression of the mitochondrial respiratory chain in older patients with sepsis [46]. Mitochondrial dysfunction is known for contributing to multiple organ failure in sepsis. Physiologically, small amounts of reactive species of oxygen are produced by complex I and III of the respiratory chain. Sepsis is characterized by an increase in oxidative stress due to increased production of neutrophils, an increase in xanthine oxidase activity, increased plasma levels of nitric oxide, and decreased antioxidant capacity of plasma [47]. Pro‐inflammatory mediators and oxidative stress deregulate the function of respiratory chain enzymes and lead to structural damage of lipids, proteins, and mitochondrial DNA [48, 49], promoting failure of multiple organs [50]. Mitochondrial damage and secondary dysfunction to oxidative stress are also characteristic of the aging process [6, 51, 52]. Mice that have defective function of mitochondrial DNA polymerase enzyme have a shorter life and show many signs of premature aging, such as alopecia, decreased physical activity, and early loss of reproductive function [53].

The mechanisms that lead to specific dysfunction of several signaling pathways in the immune response of older people are complex and involve multiple factors. We propose that environmental factors [54, 55], microRNAs [56], and epigenetic changes [57] play a major role in modulating the immune response cascades that are particularly affected in older patients.

Our data confirm previous reports that aging is accompanied by changes in gene expression of immune system pathways [58]. Another important result of our research group shows that noncoding long RNA subgroups are deregulated in sepsis and during the aging process. Therefore, extensive studies are required to investigate the biological role played by this class of transcripts in septic shock in older individuals.


4. Conclusion

There is great expectation that studying biological systems can provide a better understanding of several complex diseases. Further information could be used to identify new therapeutic targets and groups of patients who should benefit from such interventions.

Using this strategy, we have identified the main pathways that are altered in older people with sepsis. Our findings highlight that the systemic inflammatory response differs depending on the population that is studied. Oxidative stress appears to play a central role, inducing various types of dysfunction, in older patients with sepsis. Moreover, we have identified several other genes and signaling pathways that are altered in these patients. This information will facilitate understanding of the nature of the immune response in this situation.


  1. 1. Iskander KN, Osuchowski MF, Stearns‐Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93(3):1247-88.
  2. 2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.
  3. 3. Yao YM, Luan YY, Zhang QH, Sheng ZY. Pathophysiological aspects of sepsis: an overview. Methods Mol Biol. 2015;1237:5-15.
  4. 4. Singer M, Deutschman CS, Seymour CW, Shankar‐Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis‐3). JAMA. 2016;315(8):801-10.
  5. 5. De Gaudio AR, Rinaldi S, Chelazzi C, Borracci T. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets. 2009;10(1):60-70.
  6. 6. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504-12.
  7. 7. Heppner HJ, Cornel S, Peter W, Philipp B, Katrin S. Infections in the elderly. Crit Care Clin. 2013;29(3):757-74.
  8. 8. Nasa P, Juneja D, Singh O. Severe sepsis and septic shock in the elderly: An overview. World J Crit Care Med. 2012;1(1):23-30.
  9. 9. Girard TD, Opal SM, Ely EW. Insights into severe sepsis in older patients: from epidemiology to evidence‐based management. Clin Infect Dis. 2005;40(5):719-27.
  10. 10. Grubeck‐Loebenstein B, Wick G. The aging of the immune system. Adv Immunol. 2002;80:243-84.
  11. 11. Plackett TP, Schilling EM, Faunce DE, Choudhry MA, Witte PL, Kovacs EJ. Aging enhances lymphocyte cytokine defects after injury. FASEB J. 2003;17(6):688-9.
  12. 12. Mascarucci P, Taub D, Saccani S, Paloma MA, Dawson H, Roth GS, et al. Age‐related changes in cytokine production by leukocytes in rhesus monkeys. Aging (Milano). 2001;13(2):85-94.
  13. 13. Weksler ME, Goodhardt M, Szabo P. The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol. 2002;24(1):35-52.
  14. 14. Shinkai S, Konishi M, Shephard RJ. Aging and immune response to exercise. Can J Physiol Pharmacol. 1998;76(5):562-72.
  15. 15. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll‐like receptor expression and function in aging. J Immunol. 2002;169(9): 4697-701.
  16. 16. Shaw AC, Goldstein DR, Montgomery RR. Age‐dependent dysregulation of innate immunity. Nat Rev Immunol. 2013;13(12):875-87.
  17. 17. Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss‐Coray T, et al. The role of inflammation in age‐related disease. Aging (Albany NY). 2013;5(1):84-93.
  18. 18. Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age‐dependent decrease in Toll‐like receptor 4‐mediated proinflammatory cytokine production and mitogen‐activated protein kinase expression. J Leukoc Biol. 2004;75(2):342-9.
  19. 19. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. 2004;76(2):291-9.
  20. 20. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine. 2000;18(16):1717-20.
  21. 21. Fagiolo U, Cossarizza A, Scala E, Fanales‐Belasio E, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23(9):2375-8.
  22. 22. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995;85(11): 3144-9.
  23. 23. Cevenini E, Monti D, Franceschi C. Inflammageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14-20.
  24. 24. Starr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014;5(2):126-36.
  25. 25. Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. Lipopolysaccharide‐induced lethality and cytokine production in aged mice. Infect Immun. 1996;64(3):769-74.
  26. 26. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG. Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock. 2003;19(4):310-3.
  27. 27. Pinheiro da Silva F, Zampieri FG, Barbeiro DF, Barbeiro HV, Goulart AC, Torggler Filho F, et al. Septic shock in older people: a prospective cohort study. Immun Ageing. 2013;10(1):21.
  28. 28. Kale S, Yende S, Kong L, Perkins A, Kellum JA, Newman AB, et al. The effects of age on inflammatory and coagulation‐fibrinolysis response in patients hospitalized for pneumonia. PLoS One. 2010;5(11):e13852.
  29. 29. Kelly E, MacRedmond RE, Cullen G, Greene CM, McElvaney NG, O’Neill SJ. Community‐acquired pneumonia in older patients: does age influence systemic cytokine levels in community‐acquired pneumonia? Respirology. 2009;14(2):210-6.
  30. 30. Kale SS, Yende S. Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness. Aging Dis. 2011;2(6):501-11.
  31. 31. Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol. 2010;8:84.
  32. 32. Christie JD. Microarrays. Crit Care Med. 2005;33(12 Suppl):S449-52.
  33. 33. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, et al. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med. 2009;37(5):1558-66.
  34. 34. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley TP. Leukocyte subset‐derived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med. 2010;11(3):349-55.
  35. 35. Cvijanovich N, Shanley TP, Lin R, Allen GL, Thomas NJ, Checchia P, et al. Validating the genomic signature of pediatric septic shock. Physiol Genomics. 2008;34(1):127-34.
  36. 36. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, et al. Genome‐level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med. 2007;13(9-10):495-508.
  37. 37. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene‐expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med. 2009;37(3):882-8.
  38. 38. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581-90.
  39. 39. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125-8.
  40. 40. Bone RC. Why sepsis trials fail. JAMA. 1996;276(7):565-6.
  41. 41. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112(1):235-43.
  42. 42. Maslove DM, Wong HR. Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med. 2014;20(4):204-13.
  43. 43. Maslove DM, Tang BM, McLean AS. Identification of sepsis subtypes in critically ill adults using gene expression profiling. Crit Care. 2012;16(5):R183.
  44. 44. Severino P, Silva E, Baggio‐Zappia GL, Brunialti MK, Nucci LA, Rigato O, Jr., et al. Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia. PLoS One. 2014;9(3):e91886.
  45. 45. Tang BM, Huang SJ, McLean AS. Genome‐wide transcription profiling of human sepsis: a systematic review. Crit Care. 2010;14(6):R237.
  46. 46. Pellegrina DVS, Severino P, Barbeiro HV, Andreghetto FM, Velasco IT, Souza HP, et al. Septic shock in advanced age: transcriptome analysis reveals altered molecular signatures in neutrophil granulocytes. PLoS One 2015;10(6):e0128341.
  47. 47. Wendel M, Heller AR. Mitochondrial function and dysfunction in sepsis. Wien Med Wochenschr. 2010;160(5-6):118-23.
  48. 48. Suliman HB, Carraway MS, Piantadosi CA. Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med. 2003;167(4):570-9.
  49. 49. Garcia‐Ruiz C, Colell A, Mari M, Morales A, Fernandez‐Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem. 1997;272(17):11369-77.
  50. 50. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107(1):57-64.
  51. 51. Cannizzo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflammaging and immunosenescence. J Proteomics. 2011;74(11):2313-23.
  52. 52. Floyd RA, Towner RA, He T, Hensley K, Maples KR. Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med. 2011;51(5):931-41.
  53. 53. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429(6990):417-23.
  54. 54. Su DM, Aw D, Palmer DB. Immunosenescence: a product of the environment? Curr Opin Immunol. 2013;25(4):498-503.
  55. 55. Muller L, Pawelec G. Aging and immunity impact of behavioral intervention. Brain Behav Immun. 2014;39:8-22.
  56. 56. Harries LW. MicroRNAs as mediators of the ageing process. Genes (Basel). 2014;5(3): 656-70.
  57. 57. Weidner CI, Wagner W. The epigenetic tracks of aging. Biol Chem. 2014.
  58. 58. de Magalhaes JP, Curado J, Church GM. Meta‐analysis of age‐related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009;25(7):875-81.

Written By

Mike Yoshio Hamasaki, Marcel Cerqueira César Machado and Fabiano Pinheiro da Silva

Submitted: 08 November 2016 Reviewed: 23 February 2017 Published: 23 August 2017